Abstract
Subunit vaccines are based on isolated pure or semi-pure microorganism components (antigens). As compared to traditional formulations based on whole pathogens (killed or attenuated), these vaccines are safer even if unable per se to boost immune responses unless supplemented by adjuvants. Nowadays, thanks to the development of high-performance gene engineering and biochemical procedures, subunit-based vaccines emerging on the market are formulated with recombinant antigens produced in bacterial, yeast or animal cells. Plant-based expression systems are turning out to be very attractive “biofactories” of recombinant antigens as well, since they ensure low-cost, rapid and easy manufacturing scaling up and intrinsic biosafety of the final product.
Nevertheless, also plant-produced recombinant antigens are per se poorly immunogenic. A few attempts to set-up strategies to obtain self-adjuvanted immunogens from plants have been made. This chapter will be mainly focused on the possibility to exploit to this aim plant heat-shock proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Germain, R.N.: Vaccines and the future of human immunology. Immunity 33, 441–450 (2010)
Plotkin, S.A., Plotkin, S.L.: The development of vaccines: how the past let to the future. Nat. Rev. Immunol. 9, 889–893 (2011)
Ulmer, J.B., Valley, U., Rappuoli, R.: Vaccine manufacturing: challenges and solutions. Nat. Biotechnol. 24, 1377–1383 (2006)
Streatfield, S.J.: Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol. J. 5, 2–15 (2007)
Lico, C., et al.: Plant-based vaccine delivery strategy. In: Baschieri, S. (ed.) Innovation in Vaccinology. From Design, Through to delivery and Testing. Springer, New York (2012)
Fischer, R., et al.: Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7, 152–158 (2004)
Newell, C.A.: Plant transformation technology. Mol. Biotechnol. 16, 53–65 (2000)
Lee, L.-Y., Gelvin, S.B.: T-DNA binary vectors and systems. Plant Physiol. 146, 325–332 (2008)
Bock, R., Khan, M.S.: Taming plastids for a green future. Trends Biotechnol. 22, 311–318 (2004)
Meyers, B., et al.: Nuclear and plastid genetic engineering of plants: comparison of opportunities and challenges. Biotechnol. Adv. 28, 747–756 (2010)
Bock, R.: Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Curr. Opin. Biotechnol. 18, 100–106 (2007)
Komarova, T.V., et al.: Transient expression systems for plant-derived biopharmaceuticals. Expert Rev. Vaccines 9, 859–876 (2010)
Sheludko, Y.V.: Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants. Recent Pat. Biotechnol. 2, 198–208 (2008)
Pogue, G.P., et al.: Making an ally from an enemy: plant virology and the new agriculture. Annu. Rev. Phytopathol. 40, 45–74 (2002)
Lico, C., Chen, Q., Santi, L.: Viral vectors for production of recombinant proteins in plants. J. Cell. Physiol. 216, 366–377 (2008)
Rybicki, E.P.: Plant-made vaccines for humans and animals. Plant Biotechnol. J. 8, 620–637 (2010)
Walmsley, A.M., Arntzen, C.J.: Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11, 126–129 (2000)
Tacket, C.O.: Plant-based oral vaccines: results of human trials. Curr. Top. Microbiol. Immunol. 332, 103–117 (2009)
Butaye, K.M.J., et al.: Approaches to minimize variation of transgene expression in plants. Mol. Breed. 16, 79–91 (2005)
Penney, C.A., et al.: Plant-made vaccines in support of the Millennium Development Goals. Plant Cell Rep. 30, 789–798 (2011)
Wilken, L.R., Nikolov, Z.L.: Recovery and purification of plant-made recombinant proteins. Biotechnol. Adv. 30, 419–433 (2012)
Santi, L., Huang, Z., Mason, H.: Virus-like particles production in green plants. Methods 40, 66–76 (2006)
D’Aoust, M.A., et al.: Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J. 6, 930–940 (2008)
D’Aoust, M.A., et al.: The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J. 8, 607–619 (2010)
Plotkin, S.A.: Vaccines: the fourth century. Clin. Vaccine Immunol. 16, 1709–1719 (2009)
Guy, B.: The perfect mix: recent progress in adjuvant research. Nat. Rev. Microbiol. 5, 505–517 (2007)
Bachmann, M.F., Jennings, G.T.: Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787–796 (2010)
Lico, C., et al.: Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine 27, 5069–5076 (2009)
Capuano, F., et al.: LC-MS/MS methods for absolute quantification and identification of proteins associated with chimeric plant oil bodies. Anal. Chem. 83, 9267–9272 (2011)
Chargelegue, D., et al.: Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infect. Immun. 73, 5915–5922 (2005)
Feder, M.E., Hoffmann, G.E.: Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu. Rev. Physiol. 61, 243–282 (1999)
Lindquist, S., Craig, E.A.: The heat-shock proteins. Annu. Rev. Genet. 22, 631–677 (1988)
Christis, C., Lubsen, N.H., Braakman, I.: Protein folding includes oligomerization – examples from the endoplasmic reticulum and cytosol. FEBS J. 275, 4700–4727 (2008)
Rutherford, S.L.: Between genotype and phenotype: protein chaperones and evolvability. Nat. Rev. Genet. 4, 263–274 (2003)
Wegele, H., Muller, L., Buchner, J.: Hsp70 and Hsp90 – a relay team for protein folding. Rev. Physiol. Biochem. Pharmacol. 151, 1–44 (2004)
Pearl, L.H., Prodromou, C.: Structure and mechanism of the HSP90 molecular chaperone machinery. Annu. Rev. Biochem. 75, 271–294 (2006)
Morano, K.A.: New tricks for an old dog. The evolving world of Hsp70. Ann. N. Y. Acad. Sci. 1113, 1–14 (2007)
Zhu, X., et al.: Structural analysis of substrate binding by the molecular chaperone DnaK. Science 72, 1606–1614 (1996)
Worrall, L.J., Walkinshaw, M.D.: Crystal structure of the C-terminal three-helix bundle subdomain of C. elegans HSP70. Biochem. Biophys. Res. Commun. 357, 105–110 (2007)
Jiang, J., Lafer, E.M., Sousa, R.: Crystallization of a functionally intact HSC70 chaperone. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62, 39–43 (2006)
Rudiger, S., Buchberger, A., Bukau, B.: Interaction of Hsp70 chaperones with substrates. Nat. Struct. Biol. 4, 342–349 (1997)
Schlecht, R., et al.: Mechanics of Hsp70 chaperones enables differential interaction with client proteins. Nat. Struct. Mol. Biol. 18, 345–351 (2011)
Nicolai, A., et al.: Human inducible Hsp70: structures, dynamics, and interdomain communication from all-atom molecular dynamics simulations. J. Chem. Theory Comput. 6, 2501–2519 (2010)
Srivastava, P.K.: Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2, 185–194 (2002)
Srivastava, P.K., Deleo, A.B., Old, L.J.: Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. U. S. A. 83, 3407–3411 (1986)
Murshid, A., Gong, J., Calderwood, S.K.: Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev. Vaccines 7, 1019–1030 (2008)
Srivastava, R.M., Khar, A.: Dendritic cells and their receptors in antitumor immune response. Curr. Mol. Med. 6, 708–724 (2009)
Nieland, T.J.F., et al.: Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. U. S. A. 93, 6135–6139 (1996)
Arnold, D., et al.: Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182, 885–889 (1995)
Blachere, N.E., et al.: Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186, 1315–1323 (1997)
MacAry, P.A., et al.: HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation. Immunity 20, 95–106 (2004)
Javid, B., MacAry, P.A., Lehner, P.J.: Structure and function: heat shock proteins and adaptive immunity. J. Immunol. 179, 2035–2040 (2007)
Basu, S., et al.: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303–313 (2001)
Basu, S., Matsutake, T.: Heat shock protein-antigen presenting cell interactions. Methods 32, 38–41 (2004)
Asea, A., et al.: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6, 435–442 (2000)
Kumaraguru, U., et al.: Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses. Cell Stress Chaperones 8, 134–143 (2003)
Buriani, G., et al.: Plant heat shock protein 70 as carrier for immunization against a plant-expressed reporter antigen. Transgenic Res. 20, 331–344 (2011)
Sugio, A., et al.: The cytosolic protein response as a subcomponent of the wider heat shock response in Arabidopsis. Plant Cell 21, 642–654 (2009)
Aparicio, F., et al.: Virus induction of heat shock protein 70 reflects a general response to protein accumulation in the plant cytosol. Plant Physiol. 138, 529–536 (2005)
Lee, J.H., Schöffl, F.: An Hsp70 antisense gene affects the expression of HSP70/HSC70, the regulation of HSF, and the acquisition of thermotolerance in transgenic Arabidopsis thaliana. Mol. Gen. Genet. 252, 11–19 (1996)
Kadota, Y., Shirasu, K.: The HSP90 complex of plants. Biochim. Biophys. Acta 1823, 689–697 (2012)
Corigliano, M.G., et al.: Plant Hsp90 proteins interact with B-cells and stimulate their proliferation. PLoS One 6, e21231 (2011)
Buriani, G., et al.: Heat-shock protein 70 from plant biofactories of recombinant antigens activate multiepitope-targeted immune responses. Plant Biotechnol. J. 10, 363–371 (2012)
Townsend, A.R., et al.: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959–968 (1986)
Oukka, M., et al.: Protection against lethal viral infection by vaccination with non immunodominant peptides. J. Immunol. 157, 3039–3045 (1996)
Doherty, P.C., Kelso, A.: Toward a broadly protective influenza vaccine. J. Clin. Invest. 118, 3273–3275 (2008)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Baschieri, S. (2014). Plant Heat-Shock Protein-Based Self-Adjuvanted Immunogens. In: Giese, M. (eds) Molecular Vaccines. Springer, Cham. https://doi.org/10.1007/978-3-319-00978-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-00978-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-00977-3
Online ISBN: 978-3-319-00978-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)